Search research articles
Contact Us
Filters
Showing results (181-190 of 227) with videos related to
Page
of 23
Sort By:
BMJ Open
|
January 4, 2022
First and second waves among hospitalised patients with COVID-19 with severe pneumonia: a comparison of 28-day mortality over the 1-year pandemic in a tertiary university hospital in Italy
Marianna Meschiari, Alessandro Cozzi-Lepri, Roberto Tonelli, et al.
Frontiers in Immunology
|
May 6, 2022
Emulation of a Target Trial From Observational Data to Compare Effectiveness of Casirivimab/Imdevimab and Bamlanivimab/Etesevimab for Early Treatment of Non-Hospitalized Patients With COVID-19
Valentina Mazzotta, Alessandro Cozzi-Lepri, Francesca Colavita, et al.
BMC Infectious Diseases
|
October 16, 2023
EuCARE-hospitalised study protocol: a cohort study of patients hospitalised with COVID-19 in the EuCARE project
Pontus Hedberg, Benedetta Varisco, Francesca Bai, et al.
Plos One
|
March 8, 2013
The association between serum biomarkers and disease outcome in influenza A(H1N1)pdm09 virus infection: results of two international observational cohort studies
Richard T Davey, Ruth Lynfield, Dominic E Dwyer, et al.
Frontiers in Immunology
|
November 1, 2023
Evaluating immunological and inflammatory changes of treatment-experienced people living with HIV switching from first-line triple cART regimens to DTG/3TC <i>vs.</i> B/F/TAF: the DEBATE trial
Andrea Cossarizza, Alessandro Cozzi-Lepri, Marco Mattioli, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
September 23, 2023
Risk of COVID-19 in-hospital mortality in people living with HIV compared to general population according to age and CD4 strata: data from the ICONA network
Andrea Giacomelli, Roberta Gagliardini, Alessandro Tavelli, et al.
Frontiers in Pharmacology
|
May 10, 2021
No Efficacy of the Combination of Lopinavir/Ritonavir Plus Hydroxychloroquine Versus Standard of Care in Patients Hospitalized With COVID-19: A Non-Randomized Comparison
Roberta Gagliardini, Alessandro Cozzi-Lepri, Andrea Mariano, et al.
Antiviral Therapy
|
September 17, 2013
Durability of lopinavir/ritonavir monotherapy in individuals with viral load ≤50 copies/ml in an observational setting
Antonella d'Arminio Monforte, Nicola Gianotti, Alessandro Cozzi-Lepri, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
April 8, 2023
Efficacy of bezlotoxumab in preventing the recurrence of Clostridioides difficile infection: an Italian multicenter cohort study
Marianna Meschiari, Alessandro Cozzi-Lepri, Adriana Cervo, et al.
Vaccines
|
December 23, 2023
Long Term Assessment of Anti-SARS-CoV-2 Immunogenicity after mRNA Vaccine in Persons Living with HIV
Alessandra Vergori, Alessandro Cozzi-Lepri, Giulia Matusali, et al.
Page
of 23
Search research articles
Search
Showing results (181-190 of 227) with videos related to
Sort By:
Page
of 23
BMJ Open
|
January 4, 2022
First and second waves among hospitalised patients with COVID-19 with severe pneumonia: a comparison of 28-day mortality over the 1-year pandemic in a tertiary university hospital in Italy
Marianna Meschiari, Alessandro Cozzi-Lepri, Roberto Tonelli, et al.
Frontiers in Immunology
|
May 6, 2022
Emulation of a Target Trial From Observational Data to Compare Effectiveness of Casirivimab/Imdevimab and Bamlanivimab/Etesevimab for Early Treatment of Non-Hospitalized Patients With COVID-19
Valentina Mazzotta, Alessandro Cozzi-Lepri, Francesca Colavita, et al.
BMC Infectious Diseases
|
October 16, 2023
EuCARE-hospitalised study protocol: a cohort study of patients hospitalised with COVID-19 in the EuCARE project
Pontus Hedberg, Benedetta Varisco, Francesca Bai, et al.
Plos One
|
March 8, 2013
The association between serum biomarkers and disease outcome in influenza A(H1N1)pdm09 virus infection: results of two international observational cohort studies
Richard T Davey, Ruth Lynfield, Dominic E Dwyer, et al.
Frontiers in Immunology
|
November 1, 2023
Evaluating immunological and inflammatory changes of treatment-experienced people living with HIV switching from first-line triple cART regimens to DTG/3TC <i>vs.</i> B/F/TAF: the DEBATE trial
Andrea Cossarizza, Alessandro Cozzi-Lepri, Marco Mattioli, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
September 23, 2023
Risk of COVID-19 in-hospital mortality in people living with HIV compared to general population according to age and CD4 strata: data from the ICONA network
Andrea Giacomelli, Roberta Gagliardini, Alessandro Tavelli, et al.
Frontiers in Pharmacology
|
May 10, 2021
No Efficacy of the Combination of Lopinavir/Ritonavir Plus Hydroxychloroquine Versus Standard of Care in Patients Hospitalized With COVID-19: A Non-Randomized Comparison
Roberta Gagliardini, Alessandro Cozzi-Lepri, Andrea Mariano, et al.
Antiviral Therapy
|
September 17, 2013
Durability of lopinavir/ritonavir monotherapy in individuals with viral load ≤50 copies/ml in an observational setting
Antonella d'Arminio Monforte, Nicola Gianotti, Alessandro Cozzi-Lepri, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
April 8, 2023
Efficacy of bezlotoxumab in preventing the recurrence of Clostridioides difficile infection: an Italian multicenter cohort study
Marianna Meschiari, Alessandro Cozzi-Lepri, Adriana Cervo, et al.
Vaccines
|
December 23, 2023
Long Term Assessment of Anti-SARS-CoV-2 Immunogenicity after mRNA Vaccine in Persons Living with HIV
Alessandra Vergori, Alessandro Cozzi-Lepri, Giulia Matusali, et al.
Page
of 23